Moreover, in 3xTg-AD mice, which express three mutations in human APP, tau, and PSEN1, a reduction in Aβ deposits by immunotherapy resulted in decreased tau inclusions (Oddo et al., 2004). Here, MAPT is linked to Alzheimer disease.